180 Wealth Advisors, LLC Astrazeneca PLC Transaction History
180 Wealth Advisors, LLC
- $789 Million
- Q3 2025
A detailed history of 180 Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 7,374 shares of AZN stock, worth $618,162. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,374
Previous 7,446
0.97%
Holding current value
$618,162
Previous $520,000
8.65%
% of portfolio
0.07%
Previous 0.08%
Shares
28 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
498MCall Options Held
7.11MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.35 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.45 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...